nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A clinical trial of supervised exercise for adult inpatients with acute myeloid leukemia (AML) undergoing induction chemotherapy
|
Alibhai, Shabbir M.H. |
|
2012 |
36 |
10 |
p. 1255-1261 7 p. |
artikel |
2 |
Angiogenic factors in chronic lymphocytic leukemia
|
Xia, Yi |
|
2012 |
36 |
10 |
p. 1211-1217 7 p. |
artikel |
3 |
CD38 gene polymorphism and risk of chronic lymphocytic leukemia
|
Abramenko, Iryna V. |
|
2012 |
36 |
10 |
p. 1237-1240 4 p. |
artikel |
4 |
Defining causative factors contributing in the activation of hedgehog signaling in diffuse large B-cell lymphoma
|
Ramirez, Elisa |
|
2012 |
36 |
10 |
p. 1267-1273 7 p. |
artikel |
5 |
Differences in blast immunophenotypes among disease types in myelodysplastic syndromes: A multicenter validation study
|
Ogata, Kiyoyuki |
|
2012 |
36 |
10 |
p. 1229-1236 8 p. |
artikel |
6 |
Distinct expression profiles of MSI2 and NUMB genes in myelodysplastic syndromes and acute myeloid leukemia patients
|
Pereira, João Kleber Novais |
|
2012 |
36 |
10 |
p. 1300-1303 4 p. |
artikel |
7 |
Editorial Board
|
|
|
2012 |
36 |
10 |
p. CO2- 1 p. |
artikel |
8 |
Hypereosinophilic syndrome in children
|
van Grotel, M. |
|
2012 |
36 |
10 |
p. 1249-1254 6 p. |
artikel |
9 |
Hypermethylation of Wnt antagonist gene promoters and activation of Wnt pathway in myelodysplastic marrow cells
|
Masala, Erico |
|
2012 |
36 |
10 |
p. 1290-1295 6 p. |
artikel |
10 |
Improving the prognostic assessment of myelodysplastic syndromes by understanding the biology of the disease
|
Della Porta, Matteo Giovanni |
|
2012 |
36 |
10 |
p. 1225-1226 2 p. |
artikel |
11 |
Incidence and survival of chronic myelomonocytic leukemia in Girona (Spain): A population-based study, 1993–2007
|
Osca-Gelis, Gemma |
|
2012 |
36 |
10 |
p. 1262-1266 5 p. |
artikel |
12 |
Induction of differentiation and apoptosis in leukaemic cell lines by the novel benzamide family histone deacetylase 2 and 3 inhibitor MI-192
|
Boissinot, Marjorie |
|
2012 |
36 |
10 |
p. 1304-1310 7 p. |
artikel |
13 |
Mechanism of immunomodulatory drugs in multiple myeloma
|
Sedlarikova, Lenka |
|
2012 |
36 |
10 |
p. 1218-1224 7 p. |
artikel |
14 |
Nilotinib and imatinib inhibit cytarabine cellular uptake: Implications for combination therapy
|
Naud, Josy S. |
|
2012 |
36 |
10 |
p. 1311-1314 4 p. |
artikel |
15 |
Older age is associated with similar quality of life and physical function compared to younger age during intensive chemotherapy for acute myeloid leukemia
|
Mohamedali, H. |
|
2012 |
36 |
10 |
p. 1241-1248 8 p. |
artikel |
16 |
Overexpression of MDR1 and survivin, and decreased Bim expression mediate multidrug-resistance in multiple myeloma cells
|
Tsubaki, Masanobu |
|
2012 |
36 |
10 |
p. 1315-1322 8 p. |
artikel |
17 |
Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia
|
Feldman, E.J. |
|
2012 |
36 |
10 |
p. 1283-1289 7 p. |
artikel |
18 |
Rituximab in combination with high-dose dexamethasone for the treatment of relapsed/refractory chronic lymphocytic leukemia
|
Smolej, Lukáš |
|
2012 |
36 |
10 |
p. 1278-1282 5 p. |
artikel |
19 |
Serum double monoclonal components and hematological malignancies: Only a casual association? Review of 34 cases
|
Guastafierro, Salvatore |
|
2012 |
36 |
10 |
p. 1274-1277 4 p. |
artikel |
20 |
Treatment with bortezomib in multiple myeloma is associated with only a transient and brief increase of bone specific alkaline phosphatase
|
Haidl, Felix |
|
2012 |
36 |
10 |
p. 1296-1299 4 p. |
artikel |
21 |
Variants of CD38 gene and lipid metabolism: A link in chronic lymphocytic leukemia?
|
Jamroziak, Krzysztof |
|
2012 |
36 |
10 |
p. 1227-1228 2 p. |
artikel |